Association of the 3,5,3'-triiodo-L-thyronine nuclear receptor with the nuclear matrix of cultured growth hormone-producing rat pituitary tumor cells (GC cells)

M. H. Kumara-Siri, L. E. Shapiro, Martin I. Surks

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The iodothyronine nuclear receptor, a nonhistone chromatin peptide, mediates growth hormone gene transcription in cultured GC cells (Yaffe, B.M., and Samuels, H.H. (1984) J. Biol. Chem. 259, 6284-6291). To determine whether the 3,5,3'-triiodo-L-thyronine (T3) receptor was localized to the nuclear matrix, we studied the subnuclear distribution of [125I]T3-receptor complexes after treatment of nuclei with DNaseI and 2 M NaCl to facilitate removal of histones. After incubation with 5 nM [125I]T3 to exchange with 80-90% of nuclear T3 receptors, the nuclear matrix fraction contained < 1% of nuclear DNA, 16.5% of nuclear protein, and 30-50% (mean, 40.0 ± 2.3%) of specifically bound [125I]T3. Control experiments showed that nuclear matrix [125]T3 did not appear exchangeable with added 5 nM T3 and did not result from release and nonspecific precipitation of [125I]T3 or [125I]T3-receptor complexes during nuclear matrix preparation. Studies with the T3 photoaffinity probe, N-2-diazo-3,3,3-trifluoropropionyl-[125I]T3 resulted in the finding of limited capacity receptor forms, 58,000 and 46,000 kDa, in the nuclear matrix. These receptor forms were identical to those observed when N-2-diazo-3,3,3-trifluoropropionyl-[125I]T3-labeled receptors were solubilized directly from nuclei. Lastly, limited capacity [125I]T3 binding was demonstrated in 0.4 M KCl buffer extracts of nuclear matrix. Binding displacement studies suggested that 46% of the binding activity solubilized from nuclear matrix exchanged with [125I]T3 and that the apparent equilibrium association constant of this binding activity was similar to that of 0.4 M KCl extracts of isolated nuclei. These results suggest that an appreciable fraction of nuclear T3 receptors is localized to the nuclear matrix and may influence the expression of thyroid hormone action.

Original languageEnglish (US)
Pages (from-to)2844-2852
Number of pages9
JournalJournal of Biological Chemistry
Volume261
Issue number6
StatePublished - 1986

Fingerprint

Thyronines
Nuclear Matrix
Thyroid Hormone Receptors
Pituitary Neoplasms
Cytoplasmic and Nuclear Receptors
Growth Hormone
Rats
Tumors
Cells
CD3 Antigens
Transcription
Nuclear Proteins
Thyroid Hormones
Histones
Chromatin
Buffers
Genes
Peptides
DNA
Cultured Cells

ASJC Scopus subject areas

  • Biochemistry

Cite this

@article{cc2441197c25451e848f4dc5ae13a063,
title = "Association of the 3,5,3'-triiodo-L-thyronine nuclear receptor with the nuclear matrix of cultured growth hormone-producing rat pituitary tumor cells (GC cells)",
abstract = "The iodothyronine nuclear receptor, a nonhistone chromatin peptide, mediates growth hormone gene transcription in cultured GC cells (Yaffe, B.M., and Samuels, H.H. (1984) J. Biol. Chem. 259, 6284-6291). To determine whether the 3,5,3'-triiodo-L-thyronine (T3) receptor was localized to the nuclear matrix, we studied the subnuclear distribution of [125I]T3-receptor complexes after treatment of nuclei with DNaseI and 2 M NaCl to facilitate removal of histones. After incubation with 5 nM [125I]T3 to exchange with 80-90{\%} of nuclear T3 receptors, the nuclear matrix fraction contained < 1{\%} of nuclear DNA, 16.5{\%} of nuclear protein, and 30-50{\%} (mean, 40.0 ± 2.3{\%}) of specifically bound [125I]T3. Control experiments showed that nuclear matrix [125]T3 did not appear exchangeable with added 5 nM T3 and did not result from release and nonspecific precipitation of [125I]T3 or [125I]T3-receptor complexes during nuclear matrix preparation. Studies with the T3 photoaffinity probe, N-2-diazo-3,3,3-trifluoropropionyl-[125I]T3 resulted in the finding of limited capacity receptor forms, 58,000 and 46,000 kDa, in the nuclear matrix. These receptor forms were identical to those observed when N-2-diazo-3,3,3-trifluoropropionyl-[125I]T3-labeled receptors were solubilized directly from nuclei. Lastly, limited capacity [125I]T3 binding was demonstrated in 0.4 M KCl buffer extracts of nuclear matrix. Binding displacement studies suggested that 46{\%} of the binding activity solubilized from nuclear matrix exchanged with [125I]T3 and that the apparent equilibrium association constant of this binding activity was similar to that of 0.4 M KCl extracts of isolated nuclei. These results suggest that an appreciable fraction of nuclear T3 receptors is localized to the nuclear matrix and may influence the expression of thyroid hormone action.",
author = "Kumara-Siri, {M. H.} and Shapiro, {L. E.} and Surks, {Martin I.}",
year = "1986",
language = "English (US)",
volume = "261",
pages = "2844--2852",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "6",

}

TY - JOUR

T1 - Association of the 3,5,3'-triiodo-L-thyronine nuclear receptor with the nuclear matrix of cultured growth hormone-producing rat pituitary tumor cells (GC cells)

AU - Kumara-Siri, M. H.

AU - Shapiro, L. E.

AU - Surks, Martin I.

PY - 1986

Y1 - 1986

N2 - The iodothyronine nuclear receptor, a nonhistone chromatin peptide, mediates growth hormone gene transcription in cultured GC cells (Yaffe, B.M., and Samuels, H.H. (1984) J. Biol. Chem. 259, 6284-6291). To determine whether the 3,5,3'-triiodo-L-thyronine (T3) receptor was localized to the nuclear matrix, we studied the subnuclear distribution of [125I]T3-receptor complexes after treatment of nuclei with DNaseI and 2 M NaCl to facilitate removal of histones. After incubation with 5 nM [125I]T3 to exchange with 80-90% of nuclear T3 receptors, the nuclear matrix fraction contained < 1% of nuclear DNA, 16.5% of nuclear protein, and 30-50% (mean, 40.0 ± 2.3%) of specifically bound [125I]T3. Control experiments showed that nuclear matrix [125]T3 did not appear exchangeable with added 5 nM T3 and did not result from release and nonspecific precipitation of [125I]T3 or [125I]T3-receptor complexes during nuclear matrix preparation. Studies with the T3 photoaffinity probe, N-2-diazo-3,3,3-trifluoropropionyl-[125I]T3 resulted in the finding of limited capacity receptor forms, 58,000 and 46,000 kDa, in the nuclear matrix. These receptor forms were identical to those observed when N-2-diazo-3,3,3-trifluoropropionyl-[125I]T3-labeled receptors were solubilized directly from nuclei. Lastly, limited capacity [125I]T3 binding was demonstrated in 0.4 M KCl buffer extracts of nuclear matrix. Binding displacement studies suggested that 46% of the binding activity solubilized from nuclear matrix exchanged with [125I]T3 and that the apparent equilibrium association constant of this binding activity was similar to that of 0.4 M KCl extracts of isolated nuclei. These results suggest that an appreciable fraction of nuclear T3 receptors is localized to the nuclear matrix and may influence the expression of thyroid hormone action.

AB - The iodothyronine nuclear receptor, a nonhistone chromatin peptide, mediates growth hormone gene transcription in cultured GC cells (Yaffe, B.M., and Samuels, H.H. (1984) J. Biol. Chem. 259, 6284-6291). To determine whether the 3,5,3'-triiodo-L-thyronine (T3) receptor was localized to the nuclear matrix, we studied the subnuclear distribution of [125I]T3-receptor complexes after treatment of nuclei with DNaseI and 2 M NaCl to facilitate removal of histones. After incubation with 5 nM [125I]T3 to exchange with 80-90% of nuclear T3 receptors, the nuclear matrix fraction contained < 1% of nuclear DNA, 16.5% of nuclear protein, and 30-50% (mean, 40.0 ± 2.3%) of specifically bound [125I]T3. Control experiments showed that nuclear matrix [125]T3 did not appear exchangeable with added 5 nM T3 and did not result from release and nonspecific precipitation of [125I]T3 or [125I]T3-receptor complexes during nuclear matrix preparation. Studies with the T3 photoaffinity probe, N-2-diazo-3,3,3-trifluoropropionyl-[125I]T3 resulted in the finding of limited capacity receptor forms, 58,000 and 46,000 kDa, in the nuclear matrix. These receptor forms were identical to those observed when N-2-diazo-3,3,3-trifluoropropionyl-[125I]T3-labeled receptors were solubilized directly from nuclei. Lastly, limited capacity [125I]T3 binding was demonstrated in 0.4 M KCl buffer extracts of nuclear matrix. Binding displacement studies suggested that 46% of the binding activity solubilized from nuclear matrix exchanged with [125I]T3 and that the apparent equilibrium association constant of this binding activity was similar to that of 0.4 M KCl extracts of isolated nuclei. These results suggest that an appreciable fraction of nuclear T3 receptors is localized to the nuclear matrix and may influence the expression of thyroid hormone action.

UR - http://www.scopus.com/inward/record.url?scp=0023000321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023000321&partnerID=8YFLogxK

M3 - Article

C2 - 3005268

AN - SCOPUS:0023000321

VL - 261

SP - 2844

EP - 2852

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 6

ER -